Skip to main content

Table 2 Number of cases with different lesion sites in the treated group and the control group (unit: pcs)

From: Efficacy of rTMS for poststroke epilepsy and its effects on patients’ cognitive function and depressive status

Lesion site

Treated

Control

Total

χ2

P

frontal lobe

16

19

35

2.375

0.667

temporal lobe

16

15

31

parietal lobe

10

12

22

occipital lobe

7

15

22

insular lobe

4

7

11

Total

53

68

121